This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Synchrony (SYF) & Veterinary Growth to Offer Pet Care Financing
by Zacks Equity Research
Synchrony (SYF) collaborates with Veterinary Growth to provide pet care financing solutions to its members.
SYF or BX: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
SYF vs. BX: Which Stock Is the Better Value Option?
Why Investors Are Retaining Blue Owl Capital (OBDC) Stock Now
by Zacks Equity Research
The high-interest rate environment is projected to drive Blue Owl Capital's (OBDC) investment income this year.
SYF vs. BX: Which Stock Is the Better Value Option?
by Zacks Equity Research
SYF vs. BX: Which Stock Is the Better Value Option?
Are Investors Undervaluing Synchrony Financial (SYF) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Here's Why Investors Are Retaining Synchrony (SYF) Stock Now
by Zacks Equity Research
Synchrony's (SYF) Health & Wellness platform is expected to continue its growth track, thanks to a solid CareCredit brand.
Synchrony's (SYF) CareCredit Offers Pet Care Financing Option
by Zacks Equity Research
Synchrony (SYF) collaborates with the University of Missouri, Oregon State University and Virginia Tech to provide pet care financing solutions.
Synchrony (SYF) Offers Financing Options in Dental Care
by Zacks Equity Research
Synchrony Financial (SYF) ties up with Specialty1 Partners to extend financing alternatives to customers opting for dental care, as well as shield them from unexpected medical expenses.
Synchrony Financial (SYF) Up 10% in 3 Months: Growth Ahead?
by Zacks Equity Research
Synchrony Financial's (SYF) focus on creating new partnerships and expanding old ones is expected to position the company for long-term growth.
Why Is Synchrony (SYF) Down 9% Since Last Earnings Report?
by Zacks Equity Research
Synchrony (SYF) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Synchrony (SYF) and Floor & Decor Partner for Financing Options
by Zacks Equity Research
Synchrony's (SYF) multi-year partnership with Floor & Decor is expected to provide customers with suitable financing and payment options.
Rithm Capital (RITM) Shares Dip 0.5% Despite Q2 Earnings Beat
by Zacks Equity Research
Rithm Capital's (RITM) Q2 results indicate strong contributions from the Residential Securities, Properties and Loans unit, partly offset by escalating general and administrative costs.
CNO Financial's (CNO) Q2 Earnings Miss on Higher Expenses
by Zacks Equity Research
CNO Financial (CNO) expects 2023 EPS in the range of $2.65-$2.85, indicating a decline from the 2022 figure of $3.06.
AMERISAFE (AMSF) Shares Fall 5.2% Despite Q2 Earnings Beat
by Zacks Equity Research
AMERISAFE's (AMSF) second-quarter results benefit from lower expenses. Improved net investment income acted as a partial offset.
Principal Financial (PFG) Q2 Earnings Miss on Higher Expenses
by Zacks Equity Research
Principal Financial's (PFG) second-quarter results are affected by deteriorating performances in most segments coupled with higher expenses.
Globe Life (GL) Q2 Earnings Top Estimates, Premiums Rise Y/Y
by Zacks Equity Research
Globe Life's (GL) second-quarter results reflect higher premiums and increased net investment income. Higher expenses and lower insurance underwriting income are the offsets.
Euronet's (EEFT) Q2 Earnings Beat on Strong epay Segment
by Zacks Equity Research
Euronet's (EEFT) Q2 results were aided by improved domestic and international cash withdrawal transactions and, promotional activity benefits, partly offset by higher direct operating expenses.
Synchrony Financial (SYF) Hikes Quarterly Dividend Payout by 9%
by Zacks Equity Research
Synchrony Financial's (SYF) recent dividend hike of 9% reflects its intention to enhance shareholders' value supported by its strong financial position.
Company News for Jul 19, 2023
by Zacks Equity Research
Companies In The News Are: SYF, NVS, SCHW, PNC.
Synchrony (SYF) Q2 Earnings Beat on Growing Interest Income
by Zacks Equity Research
Synchrony Financial's (SYF) average active accounts have increased 1% year over year to 69.5 million in the second quarter.
SYF or AVTA: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
SYF vs. AVTA: Which Stock Is the Better Value Option?
Are Investors Undervaluing StoneX Group (SNEX) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Synchrony (SYF) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for Synchrony (SYF) give a sense of how the business performed in the quarter ended June 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Synchrony (SYF) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Synchrony (SYF) delivered earnings and revenue surprises of 8.20% and 2.08%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Why Earnings Season Could Be Great for Synchrony Financial (SYF)
by Zacks Equity Research
Synchrony Financial (SYF) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.